Abnormalities of small intestinal endocrine cells in non-obese diabetic mice

Journal of Diabetes and its Complications

Volumn 12, Issue 4, 1998, Pages 215-223

  El Salhy, M ^a   Zachrisson, S ^a   Spangeus A ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GASTRIN; SECRETIN; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; DIABETES MELLITUS; DUODENUM; ENDOCRINE CELL; FEMALE; GASTROINTESTINAL DISEASE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANIMALS; DIABETES MELLITUS, TYPE 1; DUODENUM; ENTEROENDOCRINE CELLS; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GASTRINS; HUMANS; ISLETS OF LANGERHANS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; RADIOIMMUNOASSAY; SECRETIN; SEROTONIN; SOMATOSTATIN; SWINE;

EID: 0031779949     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00110-4     Document Type: Article

References (40)

1. Locke G.R. III Epidemiology of gastrointestinal complications of diabetes mellitus. Eur J Gastroenterol Hepatolog. 7:1995;711-716.
2. Bucceri A.M., Brogna A., Ferrara R. Sonographic study of postpradial gallbladder emptying and common bile duct changes in patients with diabetes or cholelithiasis. Abdom Imaging. 19:1994;427-429.
3. Feldman M., Schiller L.R. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 98:1983;378-384.
4. Clouse R.E., Lustman P.J. Gastrointestinal symptoms in diabetic patients. Lack of association with neuropathy Am J Gastroenterol. 84:1989;868-872.
5. Allescher H.D. Postulated physiological and pathophysiological roles on motility. Daniel E.E. Neuropeptides Function in Gastrointestinal Tract. 1991;39-400 CRC Press, Boca Raton.
6. Ekblad E., Håkanson R., Sundler F. Microanatomy and chemical coding of peptide-containing neurones in the digestive tract. Daniel E.E. Neuropeptides Function in Gastrointestinal Tract. 1991;131-180 CRC Press, Boca Raton.
7. Rangachari P.K. Effects of neuropeptides on intestinal ion transport. Daniel E.E. Neuropeptides Function in Gastrointestinal Tract. 1991;429-446 CRC Press, Boca Raton.
8. Nwokolo C.U., Debnam E.S., Booth J.D., Sim R., Sankey E.A., Dhillon A.P.et al. Neuroendocrine changes in rat stomach during experimental diabetes mellitus. Dig Dis Sci. 3:1992;751-756.
9. Portela-Gomes G.M., Wilander E., Grimelius L., Bergström R., Ruhn G. The enterochromaffin cells in the mouse gastrointestinal tract after streptozotocin treatment. Pathol Res Pract. 186:1990;260-264.
10. Di Giulio A.M., Tenconi B., La Croix R., Mantegazza P., Cattabeni F., Gorio A. Denervation and hyperinnervation in the nervous system of diabetic animals. I. The autonomic neuronal dystrophy of the gut. J Neurosci Res. 24:1989;355-361.
11. Belai A., Lincoln J., Milner P., Burnstock G. Differential effect of streptozotocin-induced diabetes on innervation of the ileum and distal colon. Gastroenterology. 100:1991;1024-1032.
12. Belai A., Burnstock G. Changes in adrenergic and peptidergic nerves in the submucous plexus of streptozotocin-diabetic rat ileum. Gastroenterology. 98:1990;1427-1436.
13. Belai A., Facer P., Bishop A., Polak J.M., Burnstock G. Effect of streptozotocin-diabetes on the level of VIP m RNA in myenteric neurones. Neuroreport. 4:1993;291-294.
14. Pinto H.C., Portela-Gomes G.M., Grimelius L., Kohnert K.-D., De Sousa J.C., Albuquerque A.M.P. The distribution of endocrine cell types of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology. 108:1995;967-974.
15. Buchan A.M. Effect of diabetes in BB Wistar rat on the peptidergic component of the enteric innervation. Digestion. 46(suppl 2):1990;142-147.
16. Lysy J., Karmeli F., Goldin E. Substance P levels in the rectal mucosa of diabetic patients with normal bowel function and constipation. Scand J Gastroenterol. 28:1993;49-52.
17. Makino S., Kunimoto K., Muraoka Y., Mitzushima Y., Katagiri K., Tochino Y. Breeding of non-obese diabetic strain of mice. Exp Anim. 29:1980;1-13.
18. Tochino Y. The NOD mouse as model of type I diabetes. CRC Crit Rev Immunol. 8:1987;49-81.
19. Kolb H. Mouse models of insulin dependent diabetes. low-dose streptozotocin-induced diabetes and non-obese diabetic (NOD) mice Diabetes Metab Rev. 3:1987;751-778.
20. El-Salhy M, Mahdavi J: Image analysis of the duodenal endocrine cells in mice with particular regard to optical densitometry. Uppsala J Med Sci in press, 1998.
21. Fujishima Y., Koike Y., Kaidoh T., Nishimura M., Yoshida T.O. Restriction fragment length polymorphism analysis of major histocompatibility complex genes in non-obese diabetic mouse strain and its sister strains. Diabetologia. 32:1989;118-125.
22. El-Salhy M., Stenling R., Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol. 28:1993;809-815.
23. El-Salhy M., Suhr O., Stenling R., Wilander E., Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut. 35:1994;1413-1418.
24. Weibel E., Elias H. Quantitative Methods in Morphology. 1967;Springer-Verlag, Berlin.
25. El-Salhy M., Sandström O., Näsström E., Mustajbasic M., Zachrisson S. Application of computer image analysis in endocrine cell quantification. Histochem J. 29:1997;249-256.
26. Berghöfer P., Peterson R.G., Schneider K., Fehmann H.C., Göke B. Incretin hormone expression in the gut of diabetic mice and rats. Metabolism. 46:1997;261-267.
27. Debas T.H., Mulvihill S.J. Neuroendocrine design of the gut. Am J Surg. 161:1991;243-249.
28. Leiter A.B., Chey W.Y., Kopin A.S. Secretin. Walsh J.H., Dockray G.J. Gut Peptides. Biochemistry and Physiology:1994;147-173 Raven, New York.
29. Ho J., Lee K.Y., Chang T.-M., Chey W.Y., Dubois A. Is secretin an enterogastrone? It is in the dog. Gastroenterology. 5:1991;A93.
30. Valenzuela J.E., Diphillipi C. Inhibition of gastric emptying in human by secretin, the octapeptide of cholecystokinin and intraduodenal fat. Gastroenterology. 81:1981;898-902.
31. Perderson R.A. Gastric inhibitory polypeptide. Walsh J.H., Dockray G.J. Gut Peptides. Biochemistry and Physiology:1994;217-260 Raven, New York.
32. Creutzfeldt W., Ebert R. New developments in the incretin concept today. Diabetologia. 28:1985;565-573.
33. Creutzfeldt W., Nauck M.A. Gut hormones and diabetes melitus. Diabetes Metab Rev. 8:1992;149-177.
34. Liddle R.A. Cholecystokinin. Walsh J.H., Dockray G.J. Gut Peptides. Biochemistry and Physiology:1994;175-216 Raven, New York.
35. Blanquet F., Bouvier M., Conella J. Effects of enkephalins and morphine on spontaneous electrical activity and on junction potentials elicited by parasympathetic nerve stimulation in cat and rabbit colon. Br J Pharmacol. 77:1982;419-426.
36. Plant O.H., Miller G.H. Effect of morphine and some other opium alkaloids on the muscular activity of the alimentary canal. J Pharmacol Exp Ther. 28:1926;245-252.
37. Schang J.C., Hemond M., Herbert M., Pilote M. How does morphine work on colonic motility? An electromyographic study in the human left and sigmoid colon. Life Sci. 38:1986;671-675.
38. Gaff J.J., Martin W.R. Opioid analgesics and antagonists. Gilman A.G., Goodman L.S., Rall T.W.et al. Pharmacological Basis of Therapeutics. 7:1985;491-503 Macmillan, New York.
39. Lincoln J., Bokor J.T., Crowe R., Griffin S.G., Haven A., Burnstock G. Myenteric plexus in streptozotocin-treated rats. Neurochemical and histochemical evidence for diabetic neuropathy in the gut. Gastroenterology. 86:1984;654-661.
40. Nakayama H., Tju M., Nakagawa S. Influence of diet on intestinal cell DNA synthesis in the diabetic rat. Diabetes. 23:1974;793-795.